Double Resistance to Imatinib and AMG 706 Caused by Multiple Acquired KIT Exon 17 Mutations in a Gastrointestinal Stromal Tumour

Gut - United Kingdom
doi 10.1136/gut.2006.115923
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

Canine and Human Gastrointestinal Stromal Tumors Display Similar Mutations in C-Kit Exon 11

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours

Cureus
2020English

Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Correction: Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Germline Mutations of KIT in Gastrointestinal Stromal Tumor (GIST) and Mastocytosis

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2016English

KIT Expression in Angiosarcomas and Fetal Endothelial Cells: Lack of Mutations of Exon 11 and Exon 17 of C-Kit

Modern Pathology
Forensic MedicinePathology
2000English

Adjuvant Imatinib Mesylate After Resection of Localised, Primary Gastrointestinal Stromal Tumour: A Randomised, Double-Blind, Placebo-Controlled Trial

The Lancet
Medicine
2009English

Relative Hypocalcaemia and Muscle Cramps in Patients Receiving Imatinib for Gastrointestinal Stromal Tumour

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy